Patents matching “antibody”

US 10538590

Photosensitizing antibody-fluorophore conjugates

The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Jan 21, 2020 · Expires Jan 16, 2040

US 10532096

Methods and compositions comprising a combination of a VEGF antagonist and an anti-CTLA-4 antibody

REGENERON PHARMACEUTICALS, INC. · Granted Jan 14, 2020 · Expires Jan 9, 2040

US 10519224

Treating headache comprising administering an antibody to calcitonin gene-related peptide

TEVA PHARMACEUTICALS INTERNATIONAL GMBH · Granted Dec 31, 2019 · Expires Dec 26, 2039

US 10519240

Anti-FGFR1c antibody-FGF21 fusion proteins

REGENERON PHARMACEUTICALS, INC. · Granted Dec 31, 2019 · Expires Dec 26, 2039

US 10501528

Immunoglobulin single variable domain antibody against RSV prefusion F protein

The United States of America, as represented by the Secretary, Health and Human Services · Granted Dec 10, 2019 · Expires Dec 5, 2039

US 10493149

Stable anti-OSMR antibody formulation

Kiniksa Pharmaceuticals, GmbH · Granted Dec 3, 2019 · Expires Nov 28, 2039

US 10479825

Antibody-mediated neutralization of Marburg virus

The Board of Regents of the University of Texas System · Granted Nov 19, 2019 · Expires Nov 14, 2039

US 10457726

Antibody and antigen-binding fragment compositions targeting cell surface antigens in tumors and methods of use thereof

UNIVERSITY OF CONNECTICUT · Granted Oct 29, 2019 · Expires Oct 24, 2039

US 10450371

Monoclonal antibody and antigens for diagnosing and treating lung disease and injury

United States Government as represented by the Department of Veterans Affairs · Granted Oct 22, 2019 · Expires Oct 17, 2039

US 10444237

Anti-pancreatic cancer monoclonal antibody and use thereof

NANJING MARKERLINE BIOMEDICAL TECHNOLOGY CO., LTD. · Granted Oct 15, 2019 · Expires Oct 10, 2039

US 10413620

Light-emitting versions of the monoclonal antibody to C3D (MAB 3D29) for imaging

The Regents of the University of Colorado, a Body Corporate · Granted Sep 17, 2019 · Expires Sep 12, 2039

US 10407495

Bispecific antibody fragments for neurological disease proteins and methods of use

ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Sep 10, 2019 · Expires Sep 5, 2039

US 10391170

Stable anti-OSMR antibody formulation

Kiniksa Pharmaceuticals, GmbH · Granted Aug 27, 2019 · Expires Aug 22, 2039

US 10383945

Methods for DNA-dependent targeting of a cell permeant antibody

THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF VERTERANS AFFAIRS · Granted Aug 20, 2019 · Expires Aug 15, 2039

US 10376582

Buffer formulations for enhanced antibody stability

Outlook Therapeutics, Inc. · Granted Aug 13, 2019 · Expires Aug 8, 2039

US 10358481

Engineered antibody constant domain molecules

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 23, 2019 · Expires Jul 18, 2039

US 10351628

Antibody fragments, compositions and uses thereof

METIS PRECISION MEDICINE SB S.R.L. · Granted Jul 16, 2019 · Expires Jul 11, 2039

US 10329338

Nucleic acid construct encoding an agonistic anti-CD40 antibody and a type I interferon

The Regents of the University of Colorado · Granted Jun 25, 2019 · Expires Jun 20, 2039

US 10278986

Antibody-siRNA conjugates and uses therefor

The Regents of the University of Colorado, a Body Corporate · Granted May 7, 2019 · Expires May 2, 2039

US 10273292

Non-HIV vaccine antigen from the vaginal microbiota capable of inducing a mucosal neutralizing protective antibody response against HIV infection

B Cell Design SAS · Granted Apr 30, 2019 · Expires Apr 25, 2039

US 10266588

Method of treating osteoarthritis with an antibody to NGF

REGENERON PHARMACEUTICALS, INC. · Granted Apr 23, 2019 · Expires Apr 18, 2039

US 10232042

Conjugates of an anti-TNF-alpha antibody

Nektar Therapeutics · Granted Mar 19, 2019 · Expires Mar 14, 2039

US 10221244

Anti-CSF1R antibody and anti PD-1 antibody combination therapy for cancer

Five Prime Therapeutics, Inc. · Granted Mar 5, 2019 · Expires Feb 28, 2039

US 10197577

Serum antibody assay for determining protection from malaria, and pre-erythrocytic subunit vaccines

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 5, 2019 · Expires Jan 31, 2039